Promoter-Capture Hi-C assays, gene expression, and transcription-factor binding data are used to construct a RUNX1-ETO-dependent dynamic gene regulatory network that maintains acute myeloid leukemia (AML). Here, RUNX1 is linked to acute myeloid leukemia.